Search Results

Filter
  • 1-10 of  8,476 results for ""PHARMACOLOGY""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Shedding light on cancer immunology at the molecular level: A quantum biochemistry study of representative PD-1/PD-L1 conformations.

  • Authors : França VLB; Department of Physiology and Pharmacology, Federal University of Ceará, 60430-270, Fortaleza, Ceará, Brazil; Department of Physics, Federal University of Ceará, Fortaleza, 60440-900, Brazil.

Subjects: Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/chemistry ; Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/metabolism ; Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/immunology

  • Source: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2024 Nov 26; Vol. 735, pp. 150832. Date of Electronic Publication: 2024 Oct 13.Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Stress response regulation of mRNA translation: Implications for antioxidant enzyme expression in cancer.

  • Authors : Kim YS; Department of Pharmacology, College of Medicine, Pennsylvania State University, Hershey, PA 17033.; Kimball SR

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/genetics ; Neoplasms*/Neoplasms*/Neoplasms*/metabolism ; Neoplasms*/Neoplasms*/Neoplasms*/pathology

  • Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2024 Nov 12; Vol. 121 (46), pp. e2317846121. Date of Electronic Publication: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Nitric oxide-based multi-synergistic nanomedicine: an emerging therapeutic for anticancer.

  • Authors : Tang Y; Chongqing Key Laboratory of Medicinal Chemistry and Molecular Pharmacology, Chongqing University of Technology, Chongqing, 400054, People's Republic of China.; College of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, China.

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; Nitric Oxide*/Nitric Oxide*/Nitric Oxide*/metabolism ; Nanomedicine*/Nanomedicine*/Nanomedicine*/methods

  • Source: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Nov 04; Vol. 22 (1), pp. 674. Date of Electronic Publication: 2024 Nov 04.Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155

Record details

×
Academic Journal

Aberrant pre-mRNA processing in cancer.

  • Authors : Biswas J; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Subjects: RNA Precursors*/RNA Precursors*/RNA Precursors*/metabolism ; RNA Precursors*/RNA Precursors*/RNA Precursors*/genetics ; Neoplasms*/Neoplasms*/Neoplasms*/genetics

  • Source: The Journal of experimental medicine [J Exp Med] 2024 Nov 04; Vol. 221 (11). Date of Electronic Publication: 2024 Sep 24.Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 2985109R Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

CRBN-PROTACs in Cancer Therapy: From Mechanistic Insights to Clinical Applications.

  • Authors : Thapa R; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India.; Bhat AA

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; Neoplasms*/Neoplasms*/Neoplasms*/metabolism ; Neoplasms*/Neoplasms*/Neoplasms*/pathology

  • Source: Chemical biology & drug design [Chem Biol Drug Des] 2024 Nov; Vol. 104 (5), pp. e70009.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101262549 Publication Model: Print Cited Medium: Internet ISSN: 1747-0285

Record details

×
Academic Journal

Suppression of non-muscle myosin II boosts T cell cytotoxicity against tumors.

  • Authors : Yang Y; State Key Laboratory of Common Mechanism Research for Major Diseases, Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.; Wen D

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/immunology ; Neoplasms*/Neoplasms*/Neoplasms*/therapy ; Neoplasms*/Neoplasms*/Neoplasms*/metabolism

  • Source: Science advances [Sci Adv] 2024 Nov; Vol. 10 (44), pp. eadp0631. Date of Electronic Publication: 2024 Nov 01.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic

Record details

×
Academic Journal

Comparing supplemental indications for cancer drugs approved in the US and EU.

  • Authors : Stoelinga J; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; School of Pharmacy, Utrecht University, Utrecht, the Netherlands.

Subjects: Drug Approval* ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy

  • Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Nov; Vol. 212, pp. 114330. Date of Electronic Publication: 2024 Sep 12.Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Radiotherapy and theranostics: a Lancet Oncology Commission.

  • Authors : Abdel-Wahab M; Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria. Electronic address: .; Giammarile F

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/radiotherapy ; Health Services Accessibility*; Humans

  • Source: The Lancet. Oncology [Lancet Oncol] 2024 Nov; Vol. 25 (11), pp. e545-e580. Date of Electronic Publication: 2024 Sep 30.Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Old concepts, new tricks: How peptide vaccines are reshaping cancer immunotherapy?

  • Authors : Liu Q; Guangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University, Nanning 530004, China.; Wu P

Subjects: Vaccines, Subunit*/Vaccines, Subunit*/Vaccines, Subunit*/immunology ; Neoplasms*/Neoplasms*/Neoplasms*/therapy ; Neoplasms*/Neoplasms*/Neoplasms*/immunology

  • Source: International journal of biological macromolecules [Int J Biol Macromol] 2024 Nov; Vol. 279 (Pt 4), pp. 135541. Date of Electronic Publication: 2024 Sep 11.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7909578 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A Comparative Clinical Pharmacology Analysis of FDA-Approved Targeted Covalent Inhibitors vs. Reversible Inhibitors in Oncology.

  • Authors : Ngo HX; Clinical Pharmacology, Genentech, Inc., South San Francisco, California, USA.; Wen YW

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacokinetics ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/adverse effects

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Nov; Vol. 116 (5), pp. 1198-1206. Date of Electronic Publication: 2024 Jul 28.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535

Record details

×
  • 1-10 of  8,476 results for ""PHARMACOLOGY""